| DIRECT COMPETITOR COMPARISON | |
| AIMM.OB | Pvt1 | RIGL | Pvt2 | Industry | | Market Cap: | 6.88M | N/A | 500.07M | N/A | 98.96M | | Employees: | N/A | N/A | 181 | 551 | 65 | | Qtrly Rev Growth (yoy): | 315.80% | N/A | N/A | N/A | 19.10% | | Revenue (ttm): | 616.00K | 900.00K1 | N/A | 8.70M1 | 13.84M | | Gross Margin (ttm): | 74.03% | N/A | N/A | N/A | 65.67% | | EBITDA (ttm): | N/A | N/A | -118.39M | N/A | -12.25M | | Oper Margins (ttm): | -60.88% | N/A | N/A | N/A | -149.46% | | Net Income (ttm): | -383.00K | -36.90M1 | -119.82M | N/A | N/A | | EPS (ttm): | -0.023 | N/A | -3.235 | N/A | -0.31 | | P/E (ttm): | N/A | N/A | N/A | N/A | 17.51 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 1.28 | | P/S (ttm): | 11.18 | N/A | N/A | N/A | 10.12 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.35 | 0.00% | 58.05B | 12.51 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.16 | 0.00% | 15.08B | 17.46 | | Genzyme Corp. | GENZ | 48.20 | 0.00% | 12.79B | 27.48 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.01 | 0.00% | 38.71B | 16.63 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.82 | 0.00% | 9.24B | 1057.55 | | Teva Pharmaceutical Industries Limited | TEVA | 55.98 | 0.00% | 49.32B | 51.22 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.80 | 0.00% | 4.22B | 20.52 | | King Pharmaceuticals Inc. | KG | 12.24 | 0.00% | 3.04B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.74 | 0.00% | 5.73B | 114.97 | | Pfizer Inc. | PFE | 18.58 | 0.00% | 149.93B | 15.43 | | Johnson & Johnson | JNJ | 64.57 | 0.00% | 178.16B | 14.10 | | GlaxoSmithKline plc | GSK | 42.09 | 0.00% | 106.70B | 13.80 | | Sanofi-Aventis | SNY | 39.70 | 0.00% | 103.66B | N/A | | Novartis AG | NVS | 54.60 | 0.00% | 124.01B | 16.35 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 42.80 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.97 | 0.00% | 66.66B | 9.23 | | Abbott Laboratories | ABT | 54.09 | 0.00% | 83.66B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.70 | 0.00% | 50.91B | 13.30 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|